awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36395984-83CA3B3E-32EA-4D86-80E6-22F34E45CA55
Q36395984-83CA3B3E-32EA-4D86-80E6-22F34E45CA55
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36395984-83CA3B3E-32EA-4D86-80E6-22F34E45CA55
Delivery of tumor-homing TRAIL sensitizer with long-acting TRAIL as a therapy for TRAIL-resistant tumors.
P2860
Q36395984-83CA3B3E-32EA-4D86-80E6-22F34E45CA55
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36395984-83CA3B3E-32EA-4D86-80E6-22F34E45CA55
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
36d148e696582ef61e5b14e51702f0763e16ccea
P2860
Randomized phase II study of dulanermin in combination with paclitaxel, carboplatin, and bevacizumab in advanced non-small-cell lung cancer.